ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,707,000 | -65.2% | 613,795 | -58.5% | 0.52% | -65.4% |
| Q4 2017 | $7,771,000 | -18.9% | 1,477,417 | -5.4% | 1.51% | -9.9% |
| Q3 2017 | $9,578,000 | -16.6% | 1,562,517 | -1.6% | 1.67% | -17.6% |
| Q2 2017 | $11,478,000 | +1.9% | 1,587,620 | -25.3% | 2.03% | +92.8% |
| Q1 2017 | $11,264,000 | +56.1% | 2,125,240 | +111.5% | 1.05% | -25.6% |
| Q4 2016 | $7,216,000 | -23.3% | 1,005,000 | 0.0% | 1.42% | -17.9% |
| Q3 2016 | $9,407,000 | +33.3% | 1,005,000 | -10.0% | 1.72% | +14.4% |
| Q2 2016 | $7,055,000 | +4.8% | 1,116,255 | -8.5% | 1.51% | +6.7% |
| Q1 2016 | $6,733,000 | +158.1% | 1,219,835 | +160.9% | 1.41% | +175.4% |
| Q4 2015 | $2,609,000 | -58.9% | 467,507 | -37.7% | 0.51% | -58.3% |
| Q3 2015 | $6,345,000 | -30.1% | 750,000 | +25.0% | 1.23% | -4.6% |
| Q2 2015 | $9,072,000 | -5.6% | 600,000 | 0.0% | 1.29% | -3.0% |
| Q1 2015 | $9,606,000 | -10.2% | 600,000 | 0.0% | 1.33% | -8.9% |
| Q4 2014 | $10,692,000 | – | 600,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |